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IT was shown in an earlier paper (Darcy, 1955) that it is possible to distinguish
the blood plasma oftumour-bearing rats from that ofcontrol rats by means ofthe
gel-diffusion technique of Ouchterlony (1948). This technique is essentially
the precipitin reaction carried out in a gel. A strong precipitating antiserum
is prepared against the antigen, in this case rat plasma (a mixture of antigens),
and the two reactants are allowed to diffuse towards one another through an agar
gel. Precipitation ofthe antigen-antibody complexes occurs in the form ofbands
or lines, each of these representing one or more antigenic components of the
original antigen mixture. Ouchterlony's method permits two such antigen
mixtures to be compared in such a way that it ispossible to tell at aglance whether
there is a component in one which is absent from the other or whether a particular
component is in substantially higher concentration in one than in the other.
The earlier study revealed several differences between the plasma of tumour-
bearing rats and their controls, the most striking being: (1) The leading band of
the normal plasma, i.e. the band that migrated in front of the others towards the
antiserum, was considerably weaker in the cancer than in the normal blood. This
band has since been found to be produced by serum albumin. (2) In the cancer
plasma this albumin band was preceded by a group of faint lines (designated as
"K" lines) which were not evident in the precipitin spectrum of the normal
plasma. Their presence appears to be due partly to the receded position of the
albumin band which thus "uncovers" them, and partly to higher concentration
or higher speed of diffusion of the antigens they represent. (3) A line present in
the cancer plasma spectrum which was absent from the normal. The substance
which this line represents could be made to appear artificially in the plasma of
normal rats by bandaging them tightly around the abdomen and not fasting them
before bleeding. (4) Certain of the other antigens in the cancer plasma appeared
to be in considerably lower concentration than in the normal, but some were
higher.
The above characteristics were observed in the plasma of rats with well-
established tumours. They were not seen in animals bearing the Walker tumour
until about 6 days after its transplantation. A preliminary study (Darcy,
unpublished) has since been made of human blood and has revealed exactly
similar changes in the serum of patients with well-established tumours. But
when serum from patients with early breast cancers was examined none of these
differences from the normal were observed. Furthermore sera from some non-
neoplastic diseases showed changes very like those of advanced cancer sera.
Accordingly, in the present investigation attention was returned to rat blood in138
an attempt to find changes during the very earliest stages of tumour growth.
One striking change was found and is reported in this paper; it is shown how-
ever, to be characteristic of normal tissue growth as well as neoplastic.
METHODS AND MATERIALS
Antisera.-Two kinds ofantisera were employed. For the first, 2 rabbits were
injected with plasma from rats with large, actively growing, primary sarcomas
induced with benzpyrene. The citrated plasma was emulsified in anequal volume
of adjuvant consisting of 1.5 parts Arlacel A to 8.5 parts Bayol F. Four ml. of
this emulsion was injected intramuscularly and this injection was repeated two
weeks later. The animals were bled 11 days after the last injection. Ten
months later a second antiserum was obtained from these rabbits after repeating
the injection, this time subcutaneously. This last antiserum gave excellent
discrimination between cancer and normal serum and was the one chiefly employed
throughout the work. It was given the abbreviation A.K.P. (for anti-cancer
plasma).
Forthe second type ofantiserum an attempt was made to heighten any possible
cancer characteristics of the immunizing rat plasma by first absorbing it with an
antiserumn prepared against normal rat plasma. To 1 volume of plasma obtained
from a rat bearing a large transplanted sarcoma, were added 16 volumes of
antiserum. After incubation for 2 hours at 37° C. and overnight at 6° C. the
precipitate was centrifuged down and the supernatant used to immunize 2 rabbits
in the manner described above except that inoculation was subcutaneous. A
second antiserum was obtained from these rabbits some months later, after inject-
ing an absorbed plasma obtained from a rat bearing a large hepatoma induced by
feeding butter yellow. These antisera were given the abbreviation A.A.K.P.
(for anti-absorbed cancer plasma.)
Animals.-All rats used were, unless otherwise stated, from a colony of
albino animals originally derived from the Wistar strain. They had been bred by
cousin matings. Males were used almost exclusively. They were bled from the
heart under ether anaesthesia after overnight fasting. Rabbits were of various
breeds obtained from dealers. They were bled from the marginal ear vein.
Gel diffusion technique.-Ouchterlony's method was followed in essentials.
One per cent New Zealand agar, clarified and dissolved in 0-8 per cent NaCl
buffered at approximately pH 7.3, was employed. MAerthiolate at a concentration
of 1 part in 5000 was incorporated in both the agar gel and in the antigens and
antisera. The petri dishes in which the reactions were being carried out were kept
in air-tight glass jars at room temperature. Two main types of configuration of
the wells in the agar gel were used, one with three wells (cf. Fig. 1), the antiserum
being placed in the bottom well and the two plasmas which were being compared,
in the top wells; the other configuration was a 5-well modification of the first,
with two additional antigen wells added to form a square (cf. Fig. 2). Plasmas
for use in the gel plates were routinely diluted with 14 parts of citrate-saline
(4 per cent sodium citrate, 1 part: 0-85 per cent NaCl, 4 parts), and sera with 19
parts of 0-85 per cent NaCl. Antisera were used either at full strength or diluted
with one part of 0.85 per cent NaCl. No refilling of the wells was done.
Photographs were taken by ultraviolet light on blue-sensitive film. The first
photograph of each plate was usually taken at 2 to 5 days,after the start of the
experiment, a second at 9 to 11 days, and a third at 2 to 3 months.
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RESULTS
Discriminatory Power of the Antisera
The first object ofthe investigation was to see whether the pattern ofprecipita-
tion shown by the blood serum from an animal with an early cancer differed in a
characteristic way from that of normal rat serum. In practice, this amounted
to a search for any asymmetry in the total precipitate pattern when plasma from
rats bearing a 5-day-old Walker tumour implant was compared side by side with
normal plasma. The first indication that any such difference existed was obtained
when an antiserum against the absorbed cancer plasma (A.A.K.P.) was used.
Fig. 1 shows the result. This antiserum gave a weak and simple spectrum of
only 4 lines as opposed to the usual 20 or more. The absorption of the antigen
used to prepare this antiserum had greatly reduced the number of its
component antigens. The figure shows no lines present on the cancer side which
are not also present on the normal side. The only apparent difference is that one
ofthe 4lines (the second, counting fromthe antiserum well) isbroader onthe cancer
side and extends nearer to the antiserum well. This indicates that the substance
responsible for this line is in higher concentration in the cancer blood than in the
normal. This not very striking difference was subsequently confirmed using
other 5-day Walker tumour plasmas and fresh normal plasmas.
When the antisera prepared against the untreated rat cancer plasma (A.K.P.)
were tested, one ofthem, too, gave a discrimination between 5-day Walker tumour
plasmas and control plasmas. The essential difference was again a line in the
spectrum which was stronger on the cancer side than on the control side (Fig. 2).
In this case the difference was more striking. Other, less striking, differences were
also noted and will be indicated later. It was clear therefore, that both types of
antisera showed that there was a substance present in normal rat blood which was
in noticeably higher concentration in the cancer blood. The magnitude of this
concentration difference was found to be considerable (see below). The question
next arose whether the substance was the same with either antiserum. This could
be tested by comparing the two antisera in a 3-well plate, with the antigen (Walker
tumour plasma) in the bottom well. The result was a clear-cut "reaction of
identity" or arc-formation between the two lines in question, indicating that the
antigen that produced them was one and the same. For most subsequent
experiments the second antiserum (A.K.P.) was used because it showed the above
concentration difference more strikingly (due to its higher content of the
corresponding antibody) and could discriminate smaller concentration differences,
and because it showed concentration differences in other antigens.
Walker tumour 1 to 5 days old
The next step was to find how early after implantation of the Walker tumour
the above change could be detected in the animal's blood. Ten rats were
implanted subcutaneously with pieces of healthy Walker tumour by trocar.
Twenty-four hours later 2 of them were bled from the heart; another pair were
bled at 2 days, other pairs at 3, 4, and 5 days. The tumour grafts were examined
at autopsy.
The plasmas of all these rats showed a strong increase in the antigen, as had
the 5-day tumour plasmas. Results with the A.K.P. serum indicated that the
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increase was greater at 3 days than at 1 day, and later results showed that the
concentration of the antigen in the serum of a rat bearing the tumour for 13 days
was about twice as great as at 5 days. One of the 5-day plasmas was
comparatively weak in the antigen, and autopsy notes stated that the tumour
in this animal was much smaller and in poorer condition than in the other 5-day
animals. This suggested that the graft in question may have been starting to
regress as happens in a proportion of these Walker tumour grafts.
To confirm the effect at 24 hours, 10 more rats bearing the tumour for that
period were bled. Allplasmas showedthe strong increase in the antigen concerned
(Fig. 3). Other differences noted were (a) the line just ahead (i.e. nearer the
antibody well) ofthe one just described was also stronger in the cancer blood than
in the control, and (b) the first line of the spectrum (produced by albumin) was
somewhat weaker in the cancer blood.
Other Cancer Bloods
Yoshida sarconma
To see whether the same change occurred with other tumours and other rat
strains, the Yoshida sarcoma was implanted subcutaneously in 8 rats of the BD-1
strain in which it grows almost as rapidly as the Walker tumour does in the albino
stock rat. Animals were bled in pairs at 1, 2, 4, and 6 days after transplantation
of the tumour. Two normal BD-1 rats of the same batch provided control
plasmas. The gel diffusion test showed that the 1-day plasmas were very little
different from the controls, although one was slightly stronger in the antigen than
the controls. The 2, 4, and 6-day plasmas however, showed a strong increase in
the substance exactly as had occurred with the Walker tumour (Fig. 4).
August tumour
This tumour which arose in the inbred August strain rats as a mammary
carcinoma grows extremely slowly in its strain of origin. It takes almost 2 weeks
after transplantation to reach a measurable size and about 3 months to kill its
host (compared with about 3 weeks for the Walker tumour). Ten August strain
rats were implanted with the tumour using rather larger grafts than usual in
order to favour any possible role played by graft-necrosis in the antigen increase.
The rats were bled in pairs, at 1, 2, 4, 8, and 16 days. One normal rat ofthe same
batch provided control blood. Of the rats bled up to 8 days only one of the 2-
day ones showed a concentration ofthe antigen which was definitely stronger than
in the control blood; it had been noted at autopsy that this animal had a larger
and better attached tumour than its companion. Several of the others showed a
slightly stronger concentration of the antigen than the control, but without a
quantitative method they could not be regarded as significant. Only the two
16-day plasmas showed a strong increase ofthe antigen; by this time the tumours
had reached a fair size, about 3 cm. x 2 cm. measured through the skin (Fig. 5).
These results suggested that the increase of the antigen in the blood was in
some way associated with tumour size or tumour growth.
Benzpyrene-induced sarcomas
This experiment was performed to see whether the antigen increase occurred
with non-transplanted tumours, and if so, how early in the process of tumour
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induction it would appear. Stock albino rats were implanted subcutaneously
with small pellets of 3: 4-benzpyrene which normally gives rise to a sarcoma in
about 75 per cent ofthe rats. The first tumours appear at about 51 months after
the implantation. Six of these rats were bled at 11 months when there was no
trace of palpable tumour. All but one were negative in the gel test (i.e. showed
no increase in the antigen). Five more rats were bled after 4- months. None
had palpable tumours. All were negative in the gel test except one. This one
was the only female present. Six more of these rats were bled at 51 months
afterimplantation ofthepellet. One ofthem had a smallvisiblelump and another
had a barely palpable lump around the pellet. The remaining rats showed no
evidence of a tumour at this time. When the plasmas were tested, those from the
2 rats with palpable lumps, and plasmas from two of the other rats, showed
definitely higher concentrations of the antigen than did the controls. But none
showed very large increases.
Control Plasmas
The first experiments were carried out comparing the cancer plasma with
normal rat plasma. The normal was invariably negative, i.e., never showed a
concentration ofthe antigen in any way comparable to that in the blood ofanimals
with the Walker tumour. Various other types of non-cancerous control plasmas
were then taken to see if the phenomenon was cancer specific.
Bandaged andfed controls
Thepreviousinvestigation hadshown that when rats were bandaged aroundthe
thorax and abdomen, and were not fasted before bleeding, anew antigen appeared
in their plasma. Itwasimportant, therefore, to seewhetherthisprocedureaffected
the antigen under consideration here. Ten rats were bandaged fairly tightly
around the lower thorax and upper abdomen with gauze bandage, and over it
plaster bandage about 2 inches wide. Another 10 were similarly bandaged but
more in the abdominal region. - Two rats from each batch were bled daily for
5 days. None were fasted before bleeding. Only one ofthe 20 plasmas showed a
concentration in the antigen which could be regarded as definitely higher than the
control. At the same time it was noted that, in animals bearing the Walker
tumour, fasting before bleeding did not affect the antigen increase.
Transplants of normal tissue
To obtain control animals comparable with the tumour-bearing ones, a series
of grafting experiments were performed in which various normal tissues were
grafted between rats of the albino stock. In the first experiment 10 rats were
grafted subcutaneously by trocar with pieces of kidney from another rat. Two
rats were bled out each day for 5 days thereafter. One of the 5-day specimens
was "positive ", i.e. it showed a concentration of the antigen as strong as one of
the weaker Walker-tumour plasmas. The rest were negative or else showed
increases which could not be declared significant by the present method.
Another 10 rats were similarly grafted with embryonic tissue, a whole 8- or
9-day rat embryo being implanted subcutaneously in each host by trocar. All
the plasmas were negative in the gel test. The experiment was then repeated
using 19-to 20-day rat embryo liver in a volume comparable to the Walker tumour
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implants. One of the hosts bled at 4 days gave a clear-cut positive (Fig. 6);
it had been noted at autopsy to have a much larger graft than its companion rat.
One of the animals bled at 24 hours showed a concentration of the antigen which
was intermediate between the normal and the Walker tumour level. The rest
were negative.
Wound healing and tissue regeneration
The last results made it unlikely that the phenomenon of the antigen increase
was specific for tumour growth and suggested that it was associated with active
growth of any tissue. To test this hypothesis, regeneration experiments were set
up.
Ten rats had the left lobe of the liver removed and were bled in pairs at 24
hours, 2, 4, 8, and 16 days. This was designed to cover the main period of
regeneration. The mass of the liver is known to be restored by 14 days after
partial hepatectomy and the peak ofmitotic activity occurs at between 2 to 8 days.
Mitotic activity has begun by 24 hours. The results were as follows: All the
hepatectomy plasmas except the 16-day ones were positive; furthermore, they
were strongly positive, except the 1-day specimens and one ofthe 8-day ones which
were relatively weak but nevertheless showed considerably stronger concentrations
of the antigen than the normal (Fig. 7). The 16-day plasmas were negative.
The experiment was repeated for kidney regeneration. Ten rats had one
kidney removed and were bled as above. The 1-day specimens were positive,
but weakly so. Of the 2-day specimens, one was weakly positive the other
strongly. Both the 4-day specimens were moderately strong positives. The S-
day specimens were negative although one had a somewhat higher concentration
of the antigen than the controls. The 16-day specimens were negative.
Finally, the experiment was repeated for skin regeneration. Ten rats were
taken as before and a circular area ofskin on their backs, 2.5 cm. in diameter, was
excised in full thickness under sterile conditions. No sutures were applied but
sterile tulle gras, gauze bandage, and finally the protective plaster bandage. The
plasmas were tested as usual and gave the following results: 1-day plasmas,
negative; 2-day plasmas, one negative and one doubtful; 4-day plasmas,
positive but not strongly so; 8-day plasmas, negative; 16-day plasmas, one
negative and one doubtful.
As a result ofthis finding sham operations were performed as ifforhepatectomy.
This procedure caused a definite but not large increase in the concentration of
the antigen. The maximum concentration reached was not as great as that for
the dermatectomy experiment. Nevertheless it suggested that a considerable
part of the antigen increase in the nephrectomy experiment (where the increase
was only moderate) was due merely to the laparotomy.
Pregnancy plasmas
As a further test for the hypothesis that the antigen increase was associated
with actively-growing tissue, plasmas were tested from rats with pregnancies
ranging from 10 to 20 days duration. All showed a very strong increase in the
antigen-at least as strong as in the tumour blood. The weakest of the series
was from the rat with the earliest pregnancy, namely 10 days (Fig. 8).
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Immature versus mature rat blood
If the tissue growth hypothesis is true, it would be expected that the blood of
young andrapidly-growing rats would have a higher concentration ofthe substance
than that of adult rats. To test this, sera from rats, 1, 2, 4 and 8 weeks of age
were compared in one gel plate. Four separate experiments were made. Each
one showed that the blood ofa 1-week-old rat had a distinctly higher concentration
of the substance than that of an 8-week-old animal.
Quantitative Aspects
It was possible to obtain a rough estimate of the increase in concentration of
the substance under study by two methods. The first was to take a normal
plasma and find how high a concentration of it had to be employed in order to
give a precipitate line identical with that in a cancer plasma used at the standard
1: 14 dilution. The end-point was taken where the two lines were as nearly as
possible equal in density, width, and distance from their own antigen wells.
When a normal plasma was compared with a 1-day Walker tumour plasma in this
way, it was found that the normal plasma had to be used in a 5 times higher con-
centration than the cancer plasma. The other method is one under development
in this laboratory. In it, an extraneous "marker" line is introduced into the
spectrum at a fixed point between the wells. The position of the line under
study is noted in relation to the marker line and compared with its position in a
series of standard dilutions. This method yielded the same result as the first,
and indicates that the increase in concentration ofthe antigen under consideration
is about five-fold at 24 hours afterimplantation ofthe Walker tumour. In another
experiment, a 13-day Walker tumour serum was examined and found to contain
approximately 10 times as much of the substance as a normal control.
It could also be observed that the concentration of the antigen which was
arbitrarily chosen as being "positive" (implying a significant difference from the
normal) was certainly not less than 100 per cent greater than that in any of the
normal plasmas studied.
Characterization of the Antigen
The first clue as to the nature of the substance was obtained when tests were
done on a sample ofrat serum albumin known to contain 4 per cent ofoa-globulin.
This sample was prepared by means of ether fractionation and kindly supplied
by Dr. Margaret Mackay. When tested in the Ouchterlony plates it gave several
subsidiary bands ofprecipitate in addition to the main albumin one. It was found
that one of the subsidiary antigens gave a reaction of identity with the antigen
under study here. It was presumed therefore that the substance was probably
an a-globulin. Confirmatory evidence was obtained by means of the technique
ofimmune-electrophoresis ofGrabar and Williams (1953). Here it was found that
the substance appeared to migrate with the a-globulins, although the possibility
that it might be a fast-moving /,-globulin could not be entirely ruled out.
A chemical approach was then made to the problem, and at the suggestion of
Professor E. Boyland, rat cancer serum was precipitated with sulphosalicylic
acid, and the supernatant, after suitable dialysis, was tested in the gel plates.
It was found to give three bands, apart from traces of other antigens. One of
the bands gave a reaction of identity with the antigen under study (Fig. 9). It
can therefore be presumed to be a mucoprotein.
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Site of Origin of the Substance
Preliminary studies have yielded no clue as to the site oforigin ofthe substance.
A saline extract made of non-necrotic, washed, and homogenized Walker tumour
tissue contained no more of the substance than would be expected from the small
amount of blood contamination still remaining. The same result was- obtained
with an extract of well-washed liver cells of a pregnant female rat.
DISCUSSION
The present experiments were begun largely in the hope of finding some
characteristic early change in the blood of cancerous rats which might be of
diagnostic value. No antigenic substance was found in the plasma ofrats bearing
early tumours which was not also present in normal rat plasma. However, one
striking quantitative difference is reported, namely, an antigenic substance in
normal blood which undergoes a large increase in concentration during tumour
growth. Twenty-four hours after implantation ofthe Walker tumour the increase
in concentration of this substance is approximately five-fold. When the slow-
growing August tumour was employed no considerable increase took place until
between 8 to 16 days after transplantation. During benzpyrene carcinogenesis
the substance had already increased in the blood when the earliest tumours were
present. Further experimentation showed that the phenomenon occurred in non-
cancerous rats whichpossessed actively-growing tissue, e.g. inanimals regenerating
liver or kidney or skin and particularly in pregnant females. The substance was
also in distinctly higher concentration in the blood of 1-week-old rats than in that
of 8-week-old rats.
EXPLANATION OF PLATES
FIG. 1.-Petri dish showing antigen-antibody reaction in agar gel. Rat cancer plasma (K)
and normal plasma (N) have been allowed to diffuse from the upper wells to meet the anti-
serum (A.A.K.P.) diffusing from the lower well. The only asymmetry is in the width of
the middle band of the precipitate. The cancer plasma is from a rat bearing a 1-day-old
Walker turmour graft.
FIG. 2.-The cancer plasma (K) is from rats bearing 3-day-old Walker tumour grafts. The
antiserum (A.K.P.) was prepared against cancer plasma. The two cancer plasmas give
a strong band of precipitate which is almost absent from the normal rat plasma (N).
FIG. 3.-I-day Walker tumour rat plasma (K) contrasted with normal rat plasma (N). The
cancer plasmas show a strong band in mid-spectrum which in the normal is diffuse. The
line ahead of this is also stronger in the cancer blood, and there are other differences.
FIG. 4.--4-day Yoshida sarcomar at plasma (K) contrasted with normal rat plasma (N) to
show the stronger mid-line of the cancer plasma.
FIG. 5.- 16-day August tumour plasma (K) showing a much stronger middle band than the
normal (N). The antiserum (A.K.P.) was here used in a dilution of 1: 1.
FIG. 6.-Plasma from rats bearing embryonic liver grafts for 4 days (E) contrasted with a
4-day Walker tumour plasma (K) and a control plasma from a rat with benzpyrene implanted
(BP) which was negative. The bottom (E) plasma is almost as strong in the antigen as
the WValker plasma.
F1G. 7.-Plasma from rats 8 days after partial hepatectomy (Hz) is contrasted with normal
rat plasma (N). The mid-band is much stronger than the normal in one of the hepatectomy
plasmas, but only slightly stronger in the other.
FIG. 8.-Plasma from rats pregnant for 10 and 20 days is contrasted with the normal.
FIG. 9.-Normal rat serum (N) and 13-day Walker tumour serum (K) are placed in the top
wells to show the position of the antigen line under study. It is much stronger in the K
serum. The third well contains a mucoprotein preparation of 13-day Walker tumour serum
(M.P.). It gives 3 main lines, at least one of which is seen to arc with the strong antigen of
the K serum.
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It seems very likely therefore, that the increase in this substance is associated
with active tissue growth rather than with a phenomenon such as tissue necrosis.
For the necrosis hypothesis does not explain the negative results obtained with
the majority of normal tissue grafts which certainly become necrotic. Nor could
necrosis account for the positive results with pregnancy, regeneration, and 1-week-
old rat plasma. On the other hand the increase of the substance appears to be
related to the growth rate of the various tumours and to the extent and duration
ofthe growth ofnormal tissue. The results suggest that the fundamental correla-
tion might be with the overall mitotic rate of the body. The number of mitoses
in a Walker tumour at 24 hours after transplantation could well be as great as in
a much larger and later August tumour, or in a regenerating liver lobe. The
failure to obtain a significant increase of the substance with most normal tissue
grafts could be explained by their relatively lowgrowth rates and the smallamount
oftissue involved. The level ofthe substance in normal blood could be accounted
for by the mitotic activity needed for normal growth, maintenance, and repair.
In short, the hypothesis that the concentration of the substance in the blood is
directly associated with the total mitotic activity of the body seems worth
considering.
It is more probable, however, that the fundamental correlation is with a
secondary effect of tissue growth. Since the substance is apparently a muco-
protein, it may be merely an expression of connective tissue activity. Connective
tissue activity cannot be ruled out in any ofthe experimental situations described.
In fact it is difficult to rule it out for any tissue growth in vivo. It is worth observ-
ing, however, that the high level of the substance in the blood during liver
regeneration appears to be out of proportion to the visible fibroblast activity.
The actual laparotomy can only account for a minor part of the increase.
The fact that the substance appears to be an a-globulin and a mucoprotein
raises the question of its identity or otherwise with similar substances reported
by other authors. Numerous reports are to be found in the literature ofincreases
of o-globulins and mucoproteins in cancer and other conditions. Butler (1951)
working in this laboratory on Brdicka's (1939) polarographic serum test found that
this method oftesting human serum, although useless as a diagnostictoolfor cancer
because of the high proportion of false positions it gave with other diseases, was
nevertheless useful for predicting the course ofthe disease. A serum mucoprotein
appeared to be responsible for the polarographic behaviour (Winzler and Smyth,
1948), and this protein appeared to migrate with the a-globulins (Boyland,
Butler and Coniway, 1951). It appears likely therefore that the substance dealt
with in the present paper may be the analogous substance in the rat to that
dealt with in man by the polarographic method. However, since sulphosalicylic
acid deproteinization of rat serum left at least three antigens, only one of which
undergoes an increase during tissue growth and is the subject ofthe present paper,
it seems that the gel diffusion method is more highly selective and could give
more accurate results.
Shetlar (1952) states that the polysaccharide content of the albumin fraction
of serum appears to be elevated in all cases in which tissue proliferation occurs
but that the polysaccharide content of the a-globulin fraction increases in fever.
This is not in accord with the present results.
Hokkanen, Pyorala and Taipali (1956) studying the serum mucoprotein of
rats bearing on ascites tumour found that it reached its maximum after the
10
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tumour began to regress. This argues against the cell-division hypothesis
proposed earlier, but it may be remarked (a) that besides the present antigen
there are other mucoprotein components in rat serum which might be responsible
for the high level and (b) it cannot be ruled out at once that there is less overall
cell-division going on in the body after the tumour begins to regress-the activity
of normal tissues, especially lymphoid and myeloid tissue, has to be taken into
account.
Lockey, Anderson and Maclagan (1956) in a survey ofthe mucoprotein content
ofserum and urine report that high levels of these substances are frequently found
in inflammation and in the collagen diseases as well as in cancer. Furthermore,
surgical operations almost always produced a marked rise. In the light of the
present results it is interesting to consider whether this rise in human serum
mucoprotein might be due to one mucoprotein only, so that ifthis substance alone
could be followed greater precision would result.
A recent report which is of great interest in the light of present findings is
that of Nisselbaum and Bernfeld (1956). These authors isolated the a-globulin
glycoproteins of the plasma of normal mice and tumour-bearing mice. The
substances were studied chemically and physically and found to be distinct from
one another. The protein preparation from the tumour-bearing animals behaved
on electrophoresis like a nearly uniform substance over a wide range of pH, while
that from normal mice was a mixture of several proteins. The authors conclude,
"it appears likely that the a-globulin isolated from tumour-bearing mice is one of
the regular constituents of normal mouse plasma a-globulin, the concentration
of which increases during tumour growth ". The present findings in the rat are
in harmony with this statement. On the other hand the earlier suggestion of
Bernfeld and Homberger (1955) based on negative results obtained with normal
and embryonic tissue grafts, that the increase of the plasma a-globulin is
specifically associated with neoplastic growth, is opposed by the present results.
It was found that if the growth of normal tissue was sufficiently vigorous, then
positive tests were obtained.
Finally, there are one or two questions concerning the gel diffusion results
that require discussion. The first is about certain assumptions made in inter-
pretation of the precipitin lines. The assumption was made throughout that
since the antigen under study gave a single line it was therefore a single substance.
This need not necessarily be so. But since a wide range of antigen dilutions
failed to split the line into components, the singleness of the antigen must be
assumed until there is good evidence to the contrary.
The other assumption was that if a line is found to be nearer the antiserum
well than another line with which it gives a "reaction of identity ", that the
antigen responsible is in higher concentration in the first case. This is usually
a safe assumption. However, if the first antigen should be of lower molecular
weight (e.g. because it was partly hydrolysed) and therefore diffused faster than
the other, the position-difference might be obtained without any actual increase
of antigen. The author has had exactly this experience with the fibrinogenline
ofrat plasma which had become infected. However, in this eventuality the faster-
diffusing antigen would be expected to give a line of different density and
appearance, ifnot a reaction of" partial identity ". Since there was no evidence
for this, the more straightforward interpretation was assumed here.
There were other antigenic changes noted in early tumour blood and it is
hoped to present a fuller study of these at a later date.
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SUMMARY
An attempt has been made to discriminate the blood plasma of rats bearing
very early tumours from that of control rats. The method used was the analysis
ofplasma antigens by means ofthe gel-diffusion technique of Ouchterlony (1948).
No antigenic substance was found in the plasma ofrats bearing early tumours
which was not alsopresent inthe controlplasma. However, one striking quantita-
tive difference is reported; namely an antigenic substance in normal blood which
undergoes a large increase in concentration during tumour growth. Twenty-four
hours after implantation of the Walker tumour this increase is approximately
five-fold. When the slow-growing August tumour was employed no substantial
increase was observed until after 8 to 16 days following transplantation. During
benzpyrene carcinogenesis the substance had already increased in the blood when
the earliest tumours were present.
Further experiments showed that the phenomenon occurred in non-cancerous
rats which possessed much actively-growing tissue, e.g. in animals regenerating
liver, kidney or skin, and also in pregnant females. The substance was found in
distinctly higher concentration in the blood of 1-week-old rats than in that of
8-week-old rats.
The substance appears to be a mucoprotein which migrates electrophoretically
with the a-globulins. Its relation to similar substances reported on the literature
is discussed.
The working hypothesis is suggested that the substance is directly associated
with cell-division.
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